BC-U001

human umbilical cord-derived mesenchymal stem cells · Beijing Baylx Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BC-U001, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis [Phase 1, Phase 2]

See pricing